Bacterial Infections and Mycoses

318 trials 133 recruiting

Filter these 318 trials by phase, country and sponsor.

Open in Search →

A study to test a single administration of three dose levels of ATX101 in healthy adults. Ended

2025-521999-56-00 Treatment of vascular hyperpermeability in patients wit 3 2025-07-16
Pharmacokinetic study of colistimethate sodium Ended

2024-520019-41-00 serious infections caused by selected aerobic gram-nega 3 2025-06-30
A single-dose, open-label, randomized, two-period, two-sequence, crossover pivotal bioequivalence study on Taromentin® 500 mg + 125 mg film-… Ended

2025-521722-15-00 infections 2 2025-06-26
Phase I single-blind clinical trial to evaluate the safety and local immune activation of a toll-like receptor 5 agonist (FLAMOD) administer… Ended

2024-515933-14-00 Pneumonia 1 2025-04-14
The pivotal bioequivalence study comparing the test product to the reference product, which belong to the group of medicines used in treatme… Ended

2024-518988-35-00 Not applicable (submitted trial is a bioequivalence in 2 2025-04-01
A randomized, single-blind, placebo-controlled, study to examine the safety, tolerability, and pharmacokinetics of M6229 administered as a 1… Ended

2024-512022-28-01 Sepsis and Septic Shock 3 2025-03-12
A Single Dose, Fast state, Crossover Replicate Bioequivalence Study of NITROFURANTOIN 100 mg prolonged-release capsules (IASIS PHARMA) vs.FU… Ended

2024-517967-22-00 healthy subjects 2 2025-02-25
Evaluation of the decolonization rate and acceptance of a complete nasal decolonization kit with povidone iodine for MRSA patients Ended

2022-500642-25-00 MRSA patients 4 2024-11-21
rIFN-Gamma 1b in Candidemia Ended

2024-510816-55-00 Candidemia 4 2024-11-08
Efficacy, safety, and dose-response of a Live Biotherapeutic Product (BGY-1601-VT, vaginal tablet) as a first-line monotherapy in women with… Ended

2023-508958-26-00 Gynaecological 7 2024-10-16
Dose-finding and safety study of a new Shigella vaccine combined with an adjuvant in the Netherlands and Zambia Ended

2023-506394-35-02 Vaccination against shigellosis (in healthy adults) 3 2024-09-12
A First-in-Human, randomised, double blind, placebo-controlled, single ascending dose trial to evaluate safety, tolerability, and pharmacoki… Ended

2023-507939-38-00 Urinary tract infections (UTIs)/complicated UTI (cUTI) 1 2024-08-28
A Phase 1, Open-Label, Non-Randomized, Single-Center, Single-Dose Study to Assess the Pharmacokinetics and Safety of ANT3310 Combined with M… Ended

2024-512617-41-00 Renal impairment 3 2024-07-19
A Study to Learn How Different Forms of Study Medicine CTB-AVP Are Taken up Into the Blood and How It Is Taken up Into The Blood When Taken … Ended

2023-507117-10-00 Complicated urinary tract infection including pyeloneph 3 2024-07-09
A Single Ascending Dose, Single-Centre Study, to Assess Pharmacokinetics, Safety and Tolerability of a Single Intramuscular Dose of Bedaquil… Ended

2023-508810-41-00 Tuberculosis 3 2024-07-01
Noradrenaline plus placebo vs noradrenaline plus terlipressin for the treatment of septic shock Ended

2024-514149-12-00 Septic Shock 5 2024-06-26
Trial to evaluate the administration of IDOR-1134-2831 vaccine in healthy participants Ended

2023-506407-26-00 Clostridioides difficile (C. difficile) 1 2024-05-28
A Single Dose, Two – stage, Fasting State, Bioequivalence Study of Rifaximin 200 mg, film-coated tablets (Antibiotice S.A.) vs. Normix® 200 … Ended

2024-510671-38-00 healthy subjects 2 2024-05-26
Temocilin vs meropenem for the treatment of infections due to Enterobacteriales Ended

2023-508440-21-00 Infections due to Enterobacteriaceae 5 2024-05-21
Maternal pertussis immunization in Finland, 4 years (MIFI-4Y) Ended

2024-510787-23-00 Pertussis 6 2024-05-07
dTap booster vaccination of health care workers (HC dTap) Ended

2024-511478-56-00 Diphtheria, tetanus, pertussis (wooping cough) 6 2024-05-03
PHARMACOKINETICS OF CEFEPIME AFTER INTRAPERITONEAL ADMINISTRATION VIA CYCLER-THERAPY IN APD PATIENTS WITHOUT PERITONITIS Ended

2023-509930-21-00 CKD 5, Peritoneal Dialysis 6 2024-05-01
A Multicenter, Randomized, Double-Blind, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin-X… Ended

2022-501952-27-00 Hospital-acquired bacterial pneumonia (HABP), including 5 2024-04-19
Comparison of three short rifamycin-based regimens to treat latent tuberculosis in patients with end-stage kidney disease. Ended

2023-506432-32-00 Latent tuberculosis infection in patients with end-stag 6 2024-04-11